Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.

Knisely JP, Yu JB, Flanigan J, Sznol M, Kluger HM, Chiang VL.

J Neurosurg. 2012 Aug;117(2):227-33. doi: 10.3171/2012.5.JNS111929. Epub 2012 Jun 15.

PMID:
22702482
2.

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery.

Tazi K, Hathaway A, Chiuzan C, Shirai K.

Cancer Med. 2015 Jan;4(1):1-6. doi: 10.1002/cam4.315. Epub 2014 Aug 28.

3.

Ipilimumab and radiation therapy for melanoma brain metastases.

Silk AW, Bassetti MF, West BT, Tsien CI, Lao CD.

Cancer Med. 2013 Dec;2(6):899-906. doi: 10.1002/cam4.140. Epub 2013 Oct 10.

4.

Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.

Golden DW, Lamborn KR, McDermott MW, Kunwar S, Wara WM, Nakamura JL, Sneed PK.

J Neurosurg. 2008 Dec;109 Suppl:77-86. doi: 10.3171/JNS/2008/109/12/S13.

PMID:
19123892
5.

Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery.

Mathew M, Tam M, Ott PA, Pavlick AC, Rush SC, Donahue BR, Golfinos JG, Parker EC, Huang PP, Narayana A.

Melanoma Res. 2013 Jun;23(3):191-5. doi: 10.1097/CMR.0b013e32835f3d90.

PMID:
23462208
6.

Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases.

Patel KR, Shoukat S, Oliver DE, Chowdhary M, Rizzo M, Lawson DH, Khosa F, Liu Y, Khan MK.

Am J Clin Oncol. 2017 Oct;40(5):444-450. doi: 10.1097/COC.0000000000000199.

PMID:
26017484
7.

Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.

Frakes JM, Figura NB, Ahmed KA, Juan TH, Patel N, Latifi K, Sarangkasiri S, Strom TJ, Chinnaiyan P, Rao NG, Etame AB.

J Neurosurg. 2015 Nov;123(5):1261-7. doi: 10.3171/2014.12.JNS141919. Epub 2015 Jul 3.

PMID:
26140482
8.

Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.

Jones PS, Cahill DP, Brastianos PK, Flaherty KT, Curry WT.

Neurosurg Focus. 2015 Mar;38(3):E5. doi: 10.3171/2014.12.FOCUS14698.

PMID:
25727227
9.

Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.

Kiess AP, Wolchok JD, Barker CA, Postow MA, Tabar V, Huse JT, Chan TA, Yamada Y, Beal K.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):368-75. doi: 10.1016/j.ijrobp.2015.01.004. Epub 2015 Mar 5.

10.

Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.

Grandhi R, Kondziolka D, Panczykowski D, Monaco EA 3rd, Kano H, Niranjan A, Flickinger JC, Lunsford LD.

J Neurosurg. 2012 Aug;117(2):237-45. doi: 10.3171/2012.4.JNS11870. Epub 2012 May 25.

PMID:
22631694
11.

Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment.

Ly D, Bagshaw HP, Anker CJ, Tward JD, Grossmann KF, Jensen RL, Shrieve DC.

J Neurosurg. 2015 Aug;123(2):395-401. doi: 10.3171/2014.9.JNS141425. Epub 2015 Mar 13.

PMID:
25768829
12.

Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.

Hall MD, McGee JL, McGee MC, Hall KA, Neils DM, Klopfenstein JD, Elwood PW.

J Neurosurg. 2014 Dec;121 Suppl:84-90. doi: 10.3171/2014.7.GKS14972.

PMID:
25434941
13.

Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.

Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, Kirkwood JM, Tarhini A, Moschos S, Lunsford LD.

J Neurosurg. 2011 Mar;114(3):769-79. doi: 10.3171/2010.5.JNS1014. Epub 2010 Jun 4.

PMID:
20524829
14.

Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.

Marcus DM, Lowe M, Khan MK, Lawson DH, Crocker IR, Shelton JW, Melton A, Maynard N, Delman KA, Carlson GW, Rizzo M.

Am J Clin Oncol. 2014 Dec;37(6):580-4. doi: 10.1097/COC.0b013e318280d7be.

PMID:
23428955
16.

Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.

Selek U, Chang EL, Hassenbusch SJ 3rd, Shiu AS, Lang FF, Allen P, Weinberg J, Sawaya R, Maor MH.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1097-106.

PMID:
15234044
17.

Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.

Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):303-9. doi: 10.1016/j.ijrobp.2011.06.1987. Epub 2011 Nov 11.

PMID:
22079723
18.

Predictors of survival in contemporary practice after initial radiosurgery for brain metastases.

Likhacheva A, Pinnix CC, Parikh NR, Allen PK, McAleer MF, Chiu MS, Sulman EP, Mahajan A, Guha-Thakurta N, Prabhu SS, Cahill DP, Luo D, Shiu AS, Brown PD, Chang EL.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):656-61. doi: 10.1016/j.ijrobp.2012.05.047. Epub 2012 Aug 14.

PMID:
22898384
19.

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.

Williams NL, Wuthrick EJ, Kim H, Palmer JD, Garg S, Eldredge-Hindy H, Daskalakis C, Feeney KJ, Mastrangelo MJ, Kim LJ, Sato T, Kendra KL, Olencki T, Liebner DA, Farrell CJ, Evans JJ, Judy KD, Andrews DW, Dicker AP, Werner-Wasik M, Shi W.

Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):22-30. doi: 10.1016/j.ijrobp.2017.05.028. Epub 2017 May 26.

PMID:
28816150
20.

Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.

Ostheimer C, Bormann C, Fiedler E, Marsch W, Vordermark D.

Int J Oncol. 2015;46(6):2439-48. doi: 10.3892/ijo.2015.2970. Epub 2015 Apr 20.

PMID:
25891163

Supplemental Content

Support Center